Liver-directed Therapies for Primary/Metastatic Hepatic Malignancies Clancy Clark, MD

Liver-directed Therapies for Primary/Metastatic Hepatic Malignancies Clancy Clark, MD

The Liver, Pancreas, and GI Oncology Update Conference at Wake Forest Baptist Health is designed for general surgeons, medical oncologists, gastroenterologists, radiation oncologists, nurse oncologists, physician assistants and nurse practitioners.


• Discuss regional therapy options for patients with primary and secondary hepatic malignancies (indications and outcomes).
• Summarize recent data on biologic therapy for hepatocellular carcinoma.
• Cite recent data on surgical outcomes of colorectal hepatic metastases with extrahepatic disease.
• Review the indications and outcomes for stereotactic bodyradiotherapy for unresectable hepatic malignancies.
• Discuss the surgical management of colorectal hepatic metastases in the era of preoperative chemotherapy.
• Identify new research findings on pancreatic cancer prevention and detection in highrisk groups.
• Identify recent advances in state-of-the-art radiologic imaging for pancreatic cancer.
• Analyze how new developments in systemic therapy have affected current treatment paradigms in pancreatic cancer.
• Discuss current surgical management of pancreatic neuroendocrine tumors.
• Summarize the role of chemoradiation for gastric cancer and its indications and outcomes.
• Describe the role of a palliative care program for patients with advanced liver, pancreas, and GI malignancies.
• Review strategies to optimize nutrition in patients with liver, pancreas, and GI cancers.
• Discuss quality of life outcomes after surgery for liver, pancreas, and GI cancers.
• Discuss the components and essential elements of a peritoneal surface malignancy center and expected clinical outcomes.

View Doctor Profile

Created by

Wake Forest MedChannel